BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 9194169)

  • 1. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.
    Nieba L; Honegger A; Krebber C; Plückthun A
    Protein Eng; 1997 Apr; 10(4):435-44. PubMed ID: 9194169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
    Jäger M; Plückthun A
    J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity.
    Kipriyanov SM; Moldenhauer G; Martin AC; Kupriyanova OA; Little M
    Protein Eng; 1997 Apr; 10(4):445-53. PubMed ID: 9194170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting.
    Jung S; Plückthun A
    Protein Eng; 1997 Aug; 10(8):959-66. PubMed ID: 9415446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria.
    Jäger M; Plückthun A
    FEBS Lett; 1999 Dec; 462(3):307-12. PubMed ID: 10622716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding.
    Proba K; Honegger A; Plückthun A
    J Mol Biol; 1997 Jan; 265(2):161-72. PubMed ID: 9020980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiferritin single-chain Fv fragment is a functional protein with properties of a partially structured state: comparison with the completely folded V(L) domain.
    Martsev SP; Chumanevich AA; Vlasov AP; Dubnovitsky AP; Tsybovsky YI; Deyev SM; Cozzi A; Arosio P; Kravchuk ZI
    Biochemistry; 2000 Jul; 39(27):8047-57. PubMed ID: 10891087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand.
    Mallender WD; Carrero J; Voss EW
    J Biol Chem; 1996 Mar; 271(10):5338-46. PubMed ID: 8621386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
    Ayala M; Balint RF; Fernández-de-Cossío L; Canaán-Haden JW; Larrick JW; Gavilondo JV
    Biotechniques; 1995 May; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
    Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
    J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.
    Arndt KM; Müller KM; Plückthun A
    J Mol Biol; 2001 Sep; 312(1):221-8. PubMed ID: 11545598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4.
    Weber-Bornhauser S; Eggenberger J; Jelesarov I; Bernard A; Berger C; Bosshard HR
    Biochemistry; 1998 Sep; 37(37):13011-20. PubMed ID: 9737882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli.
    Pantoliano MW; Bird RE; Johnson S; Asel ED; Dodd SW; Wood JF; Hardman KD
    Biochemistry; 1991 Oct; 30(42):10117-25. PubMed ID: 1931943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered turns of a recombinant antibody improve its in vivo folding.
    Knappik A; Plückthun A
    Protein Eng; 1995 Jan; 8(1):81-9. PubMed ID: 7770457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody scFv fragments without disulfide bonds made by molecular evolution.
    Proba K; Wörn A; Honegger A; Plückthun A
    J Mol Biol; 1998 Jan; 275(2):245-53. PubMed ID: 9466907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.
    Kaufmann M; Lindner P; Honegger A; Blank K; Tschopp M; Capitani G; Plückthun A; Grütter MG
    J Mol Biol; 2002 Apr; 318(1):135-47. PubMed ID: 12054774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
    Arndt KM; Müller KM; Plückthun A
    Biochemistry; 1998 Sep; 37(37):12918-26. PubMed ID: 9737871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the hepatitis C virus NS3 protease activity by Fv fragment of antibody 8D4.
    Kasai N; Tsumoto K; Niwa S; Misawa S; Ueno T; Hayashi H; Kumagai I
    Biochem Biophys Res Commun; 2001 Feb; 281(2):416-24. PubMed ID: 11181064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.